57: Outcomes for allogeneic transplantation in imatinib-refractory chronic myeloid leukaemia (CML) are equivalent to outcomes in imatinib-responsive/imatinib-naive CML and can be predicted by the EBMT risk score

✍ Scribed by S.T. Durrant; S. Stylian; R.J. Western; J.P. Morton; J. Butler; C. Hutchins; G. Hill; G.A. Kennedy

• Book ID: 116279238
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 63 KB
• Volume: 13
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2006.12.060